跳至主要内容
临床试验/CTRI/2024/07/070880
CTRI/2024/07/070880尚未招募不适用

A collaborative network on respiratory disease epidemiology in India and capacity building

Society For Applied Studies3 个研究点 分布在 1 个国家目标入组 2,482 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
2,482
试验地点
3
主要终点
To determine the burden (incidence) of ARI and ALRI and the relative contribution of the viral causes (cumulative and individually) in ALRI

研究概览

简要总结

This is an observational, prospective, multi-site study which will be conducted in the community and hospitals at three sites in the country, namely, SAS Delhi, KEMHRC Pune and CMC Vellore to improve understanding of the epidemiology of Acute Respiratory Illnesses (ARI) and Acute Lower Respiratory Infections (ALRI) in under-five children.

We will use a two-tiered approach to capture the complete spectrum of illness. The community- based surveillance will provide information on  mild to moderate illness while the hospital-based surveillance will provide information on severe disease.

A cohort of 335 newborns within 14 days of birth will be enrolled from the community at each site and be actively followed up for a period of two years. Active weekly contacts will be made for each child under surveillance to identify symptoms of PSBI or ARI from birth up for 24 months. For each episode of ARI or PSBI in a child, daily contact will be established and continued until resolution of the ARI or PSBI episode. Nasopharyngeal (NP) swab will be collected from the child with ARI or PSBI at home or at study clinic within 5 days of symptom onset. In children with pneumonia or ALRI, the collected NP swabs will be sent to the central lab for multiplex rt-PCR assay to test for the viral pathogens. Also, a blood sample (3 mL) will be collected at 4-6 weeks from onset of the episode to ascertain antibody response to the infection.

Blood specimen will be collected from the mother after live child birth within 14 days and from the child in the first year of life at 3, 6 and 9 months (from 1/3 of the cohort at each time point)  and at 24 months age from the entire cohort for serosurvey of RSV and Flu infections.

Hospital-based surveillance will be conducted in the secondary/tertiary healthcare facilities of the three study sites. The aim of the hospital-based surveillance is to assess the burden of illnesses due to viral respiratory pathogens which contribute to SARI/sepsis related hospitalizations in under five children. A cohort of 514 children less than 5 years of age hospitalized with SARI will be enrolled at each site over a period of two years. Nasopharyngeal swab will be collected from the respiratory tract of all participants. To study long-term sequelae of disease, all the children hospitalized with severe ARI will be contacted at 90 days after discharge

To study household transmission patterns, a household sub-study will be conducted in the community cohort. Information on symptoms  of respiratory illness in the preceding and following 2 weeks and weekly NP swabs for 2 consecutive weeks, from household contacts of the index child with pneumonia or ALRI will be collected. All members residing in the household will be considered as household contacts.

The socio-cultural practices in the community related to ARI in children including awareness, practices, treatment seeking behaviour, facilitators, and barriers will be studied.

The outcome of the study is to determine the burden of ARI and ALRI and the relative contribution of the viral causes in ALRI, single vs co-infections, spectrum of illness and seasonal and spatial trends.

The study also aims to determine predictors of severe disease, case fatality and disease outcomes, long-term sequelae among children with ARI and ALRI; along with studying awareness and practices, treatment seeking behaviours and antibiotic use related to ARI and ALRI using mix of qualitative and quantitative methods.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Day(s) 至 14.00 Day(s)(—)
性别
All

入选标准

  • 1.Live birth 2.Available for enrolment within 14 days of birth 3.Family planning to stay in the study area until 2 years after childbirth 4.Parental consent for participation of their child Tier 2 1.Under-five children hospitalized for following respiratory infection symptoms, cough, shortness of breath with RR more than 60 for infant below 2 months, more than 50 for infants 2-12 months and more than 40 for children above 1 year, onset within the past 10 days 2.Contact at 90 days after discharge is feasible 3.Additional criteria for infants 0-6 months age, Apnoea, Sepsis, fever (more than equal to 37.5°C) or hypothermia (less than 35.5°C), shock (lethargy, fast breathing, cold skin, prolonged capillary refill, or fast weak pulse), seriously ill with no apparent cause 4.Parental consent for participation of their child.

排除标准

  • 1.Twins or triplets 2.Documented birth weight under 1500 grams or weight under 1500 grams at enrolment 3.Gestational age less than 32 weeks 4.HIV positive or born to women with known HIV infection For Tier 2: 1.Presenting complaints/diagnosis for hospitalization are non-respiratory 2.Respiratory infection is healthcare associated i.e. presenting complaints of cough or shortness of breath began 48 hours after admission. 3.Diagnosed case of HIV or primary immunodeficiency 4.Children receiving chemotherapy or immunomodulator therapy 5.Children with major congenital anomalies affecting the cardiovascular, neural and respiratory system
  • as per investigator evaluation.

结局指标

主要结局

To determine the burden (incidence) of ARI and ALRI and the relative contribution of the viral causes (cumulative and individually) in ALRI

时间窗: 24 months

次要结局

  • To understand mono vs co-infections, spectrum of illness & seasonal & spatial trends.(24 months)
  • To determine predictors of severe disease, case fatality & disease outcomes, long-term sequelae among children with ARI & ALRI(24 months)
  • To study awareness & practices, treatment seeking behaviours & antibiotic use related to ARI & ALRI using mix of qualitative & quantitative methods(24 months)

研究者

申办方类型
Research institution
责任方
Principal Investigator
主要研究者

Dr Temsunaro Rongsen Chandola

Society for Applied Studies

研究点 (3)

Loading locations...

相似试验

An observational study to understand viral causes of... | 临床试验